diltiazem has been researched along with hydralazine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (57.14) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Nara, Y; Note, S; Sato, T; Yamori, Y | 1 |
| Ogihara, M | 1 |
| Bingham, WT; Duncan, WJ; Kasian, GF; Mersal, A; Ninan, A; Sankaran, K; Tyrrell, MJ | 1 |
| Nagao, T; Nakajima, H; Narita, H; Yamaguchi, I | 1 |
| Schroeder, JS | 1 |
| Russell, IJ; Walsh, RA | 1 |
| Nagao, T; Narita, H; Yabana, H; Yamaguchi, I | 1 |
| Acconcia, MC; Gaspardone, A; Pannarale, G; Valente, A | 1 |
| Achimastos, A; Levenson, J; Safar, M; Simon, A; Temmar, M | 1 |
| Benetos, AM; Bouthier, JE; Levenson, JA; Safar, ME; Simon, AC | 1 |
| Howes, LG; Hutchinson, JS; Takata, Y | 1 |
| Zsotér, TT | 1 |
| Kawashima, A; Koike, H; Nishio, S; Ueno, Y | 1 |
| Agodoa, LY; Appel, LJ; Bakris, GL; Charleston, J; Contreras, G; Gabbai, F; Greene, T; Hiremath, L; Jamerson, K; Kendrick, C; Kusek, JW; Lash, JP; Lea, J; Miller, ER; Phillips, RA; Rahman, M; Rostand, S; Toto, R; Wang, X; Wright, JT | 1 |
4 review(s) available for diltiazem and hydralazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Combination therapy with isosorbide dinitrate: current status and the future.
Topics: Angina Pectoris; Coronary Vasospasm; Diltiazem; Drug Therapy, Combination; Esophageal Achalasia; Exercise Test; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nifedipine; Nitroprusside; Propranolol; Verapamil | 1985 |
[Early pulmonary hypertension: current therapeutic prospectives].
Topics: Calcium Channel Blockers; Captopril; Diazoxide; Diltiazem; Humans; Hydralazine; Hypertension, Pulmonary; Isoproterenol; Nifedipine; Phentolamine; Time Factors | 1982 |
Calcium antagonists.
Topics: Action Potentials; Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Bronchial Spasm; Calcium; Diazoxide; Diltiazem; Hemodynamics; Humans; Hydralazine; Lanthanum; Muscle, Smooth; Myocardial Contraction; Nifedipine; Nitrites; Nitroprusside; Papillary Muscles; Verapamil | 1980 |
2 trial(s) available for diltiazem and hydralazine
| Article | Year |
|---|---|
Treatment of pulmonary hypertension with diltiazem in a child with bronchopulmonary dysplasia.
Topics: Albuterol; Bronchopulmonary Dysplasia; Child, Preschool; Diltiazem; Humans; Hydralazine; Hypertension, Pulmonary; Infant, Newborn; Isoproterenol; Male; Nifedipine; Oxygen Inhalation Therapy; Pulmonary Heart Disease | 1988 |
A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Black or African American; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Diltiazem; Drug Administration Schedule; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hydralazine; Hypertension; Male; Middle Aged; Ramipril; Renal Insufficiency, Chronic; Treatment Outcome | 2013 |
15 other study(ies) available for diltiazem and hydralazine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Effect of calcium antagonists on hypertension and diabetes in new hypertensive diabetic models.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Diltiazem; Disease Models, Animal; Female; Glucose Tolerance Test; Heart; Hydralazine; Hypertension; Kidney; Nifedipine; Organ Size; Rats; Rats, Inbred SHR | 1987 |
Effects of calcium channel blockers and hydralazine on epinephrine-induced hyperglycemia in vivo.
Topics: Animals; Calcium Channel Blockers; Diltiazem; Epinephrine; Food Deprivation; Glucose Tolerance Test; Hydralazine; Hyperglycemia; Male; Nicardipine; Nifedipine; Rats; Rats, Inbred Strains; Verapamil | 1989 |
Calcium entry blockers: antihypertensive and natriuretic effects in experimental animals.
Topics: Angiotensin II; Animals; Blood Pressure; Calcium Channel Blockers; Diltiazem; Dogs; Glomerular Filtration Rate; Heart Rate; Hydralazine; Kidney; Natriuresis; Nifedipine; Rana catesbeiana; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Renin-Angiotensin System; Urinary Bladder | 1985 |
Selection of vasodilator therapy for severe Raynaud's phenomenon by sequential arterial infusion.
Topics: Adult; Diltiazem; Female; Humans; Hydralazine; Infusions, Intra-Arterial; Male; Phenoxybenzamine; Plethysmography; Raynaud Disease; Regional Blood Flow; Tolazoline; Vasodilator Agents | 1985 |
Hypotensive and diuretic actions of diltiazem in spontaneously hypertensive and Wistar Kyoto rats.
Topics: Animals; Benzazepines; Blood Pressure; Diltiazem; Diuresis; Heart Rate; Hydralazine; Hypertension; Male; Natriuresis; Rats; Rats, Inbred Strains; Water-Electrolyte Balance | 1983 |
[Comparative hemodynamic effects of 2 vasodilators: dihydralazine and diltiazem in permanent essential arterial hypertension].
Topics: Adult; Arteries; Arterioles; Benzazepines; Blood Pressure; Dihydralazine; Diltiazem; Heart Rate; Hemodynamics; Humans; Hydralazine; Hypertension; Middle Aged; Vascular Resistance; Vasodilator Agents | 1982 |
Baroreflex response and vasodilating drugs in essential hypertension.
Topics: Adult; Benzazepines; Blood Pressure; Brachial Artery; Dihydralazine; Diltiazem; Heart Rate; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Male; Middle Aged; Pressoreceptors; Reflex; Vascular Resistance | 1983 |
Antihypertensive effect of diltiazem in young or adult rats of genetically hypertensive strains.
Topics: Age Factors; Animals; Benzazepines; Blood Pressure; Depression, Chemical; Diltiazem; Dose-Response Relationship, Drug; Female; Hydralazine; Hypertension; Male; Rats; Rats, Inbred Strains; Time Factors | 1983 |
Effect of beraprost sodium, a stable prostacyclin analogue, on pulmonary thromboembolism in mice.
Topics: Administration, Oral; Alprostadil; Animals; Aspirin; Bridged Bicyclo Compounds; Collagen; Diltiazem; Drug Evaluation, Preclinical; Epinephrine; Epoprostenol; Fatty Acids, Monounsaturated; Fibrinolytic Agents; Heparin; Hydralazine; Injections, Intravenous; Isosorbide Dinitrate; Male; Mice; Nifedipine; Nitroprusside; Platelet Aggregation Inhibitors; Pulmonary Embolism; Superoxide Dismutase; Vasodilator Agents | 1995 |